Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 165

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 19
Chunk 165
---
Item 19. Exhibits

The following exhibits are filed as part of this
Annual Report on Form 20-F:

EXHIBIT INDEX

  Exhibit      Description                                                                                                                                                                                           
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      1.1      Constitution of Radiopharm Theranostics Limited (incorporated by reference to Exhibit 1.1 to the Company’s Post-Effective Amendment to the Registration Statement on Form 20-F (File No. 001-4162...  
      2.1      Form of Deposit Agreement between Radiopharm Theranostics Limited and Deutsche Bank Trust Company Americas as Depositary (incorporated by reference to Exhibit 2.1 to the Company’s Post-Effectiv...  
      2.2      Form of Amendment to Deposit Agreement between Radiopharm Theranostics Limited and Deutsche Bank Trust Company Americas as Depositary (incorporated by reference to Exhibit 2.2 to the Company’s ...  
      2.3      Form of American Depositary Receipt (included in Exhibit 2.2)                                                                                                                                         
     2.4*      Description of securities (American Depositary Shares)                                                                                                                                                
      4.1      Omnibus Incentive Plan (incorporated by reference to Exhibit 4.1 to the Company’s Post-Effective Amendment to the Registration Statement on Form 20-F (File No. 001-41621) filed with the SEC on ...  
      4.2      Service Agreement, dated August 1, 2021, between Radiopharm Theranostics (USA) Inc and Riccardo Canevari (incorporated by reference to Exhibit 4.2 to the Company’s Post-Effective Amendment to t...  
      4.3      Service Agreement, dated July 28, 2021, between Radiopharm Theranostics (USA) Inc and Thom Tulip (incorporated by reference to Exhibit 4.3 to the Company’s Post-Effective Amendment to the Regis...  
      4.4      Form of Deed of Indemnity with Directors (incorporated by reference to Exhibit 4.4 to the Company’s Post-Effective Amendment to the Registration Statement on Form 20-F (File No. 001-41621) file...  
     4.5#      Exclusive License Agreement,